Bioequivalence Study Between Adagrasib Reference Tablets and High Drug Load Tablets

NCT06801418 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Adagrasib

Sponsor

Mirati Therapeutics Inc.